Abstract
Prostate adenocarcinoma is the most diagnosed cancer among men [1]. This highly prevalent disease in the localized stage is often tackled with either whole gland treatment (radical prostatectomy or radiation) vs. active surveillance [2-4]. However, in recent times there has been a push towards focal therapy with goals of eradicating significant cancer within the prostate while preserving genitourinary function [5,6]. Trans-rectal High-Intensity Focused Ultrasound (HIFU) ablation of prostate tissue) HIFU for prostate cancer, recently approved by the FDA offers patients and providers another treatment option to consider in management of this disease [7]. Thus, it is imperative that information that patients peruse be reliable and of good quality.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
